Sahinturk, S. 2023. Cilostazol induces vasorelaxation through the activation of the eNOS/NO/cGMP pathway, prostanoids, AMPK, PKC, potassium channels, and calcium channels.. Prostaglandins & other lipid mediators , vol.169 , 106782.

Sahinturk, S., (2023). Cilostazol induces vasorelaxation through the activation of the eNOS/NO/cGMP pathway, prostanoids, AMPK, PKC, potassium channels, and calcium channels.. Prostaglandins & other lipid mediators , vol.169, 106782.

Sahinturk, SERDAR. "Cilostazol induces vasorelaxation through the activation of the eNOS/NO/cGMP pathway, prostanoids, AMPK, PKC, potassium channels, and calcium channels.," Prostaglandins & other lipid mediators , vol.169, 106782, 2023

Sahinturk, SERDAR. "Cilostazol induces vasorelaxation through the activation of the eNOS/NO/cGMP pathway, prostanoids, AMPK, PKC, potassium channels, and calcium channels.." Prostaglandins & other lipid mediators , vol.169, pp.106782, 2023

Sahinturk, S. (2023) . "Cilostazol induces vasorelaxation through the activation of the eNOS/NO/cGMP pathway, prostanoids, AMPK, PKC, potassium channels, and calcium channels.." Prostaglandins & other lipid mediators , vol.169, p.106782.

@article{article, author={SERDAR ŞAHİNTÜRK}, title={Cilostazol induces vasorelaxation through the activation of the eNOS/NO/cGMP pathway, prostanoids, AMPK, PKC, potassium channels, and calcium channels.}, journal={Prostaglandins & other lipid mediators}, year=2023, pages={106782} }